If you and your oncology team are considering Breast Cancer Index®, you’re taking an important step in reducing uncertainty around treating your breast cancer.
Breast Cancer Index may improve clarity for you and your doctor as you consider the duration of your anti-estrogen therapy – in fact, it’s the only validated, commercially available test that can tell you whether you’re likely to benefit from treatment beyond 5 years.
Breast Cancer Index is a test that provides individualized information to help you and your doctor make a decision about extending anti-estrogen therapy beyond 5 years for early-stage hormone receptor–positive (HR+) breast cancer. The test provides two pieces of valuable information to help make a personalized decision:
Breast Cancer Index may be right for you if you are looking for more information to help you and your doctor determine your treatment plan beyond year 5, and if you:
Download The Conversation Guide
We'll give you the resources to start the BCI conversation with your doctor. Once your healthcare provider had ordered the test, you don't need to do a thing. Tissue from your original biopsy is sent to our lab. Your results will be sent to your doctor, who will review the test report with you.